Over het archief
Het OWA, het open archief van het Waterbouwkundig Laboratorium heeft tot doel alle vrij toegankelijke onderzoeksresultaten van dit instituut in digitale vorm aan te bieden. Op die manier wil het de zichtbaarheid, verspreiding en gebruik van deze onderzoeksresultaten, alsook de wetenschappelijke communicatie maximaal bevorderen.
Dit archief wordt uitgebouwd en beheerd volgens de principes van de Open Access Movement, en het daaruit ontstane Open Archives Initiative.
Basisinformatie over ‘Open Access to scholarly information'.
| one publication added to basket [307951] |
A new Iq-peptide of the Kunitz type from the Heteractis magnifica sea anemone exhibits neuroprotective activity in a model of Alzheimer's disease
Kvetkina, A.N.; Leychenko, E.V.; Yurchenko, E.A.; Pislyagin, E.A.; Peigneur, S.; Tytgat, Y.; Isaeva, M.P.; Aminin, D.L.; Kozlovskaya, E.P. (2018). A new Iq-peptide of the Kunitz type from the Heteractis magnifica sea anemone exhibits neuroprotective activity in a model of Alzheimer's disease. Russian Journal of Bioorganic Chemistry 44(4): 416-423. https://dx.doi.org/10.1134/S106816201804012X
In: Russian Journal of Bioorganic Chemistry. MAIK NAUKA/INTERPERIODICA/SPRINGER: New York. ISSN 1068-1620; e-ISSN 1608-330X, meer
|  |
| Trefwoorden |
Heteractis magnifica (Quoy & Gaimard, 1833) [WoRMS]
Marien/Kust |
| Author keywords |
sea anemone; Kunitz-type protease inhibitors; neuroprotective activity |
| Auteurs | | Top |
- Kvetkina, A.N.
- Leychenko, E.V.
- Yurchenko, E.A.
|
- Pislyagin, E.A.
- Peigneur, S., meer
- Tytgat, Y.
|
- Isaeva, M.P.
- Aminin, D.L.
- Kozlovskaya, E.P.
|
| Abstract |
The HMIQ3c1 recombinant peptide (6434 Da), the Kunitz-type protease inhibitor, which belonged to the new group of the IQ-peptides from the Heteractis magnifica sea anemone was prepared. The inhibitory constant of trypsin by this peptide proved to be 5.0 × 10–8 M. rHMIQ3c1 was shown to have no interaction with eight isoforms of Kv1 channels. This peptide exhibited neuroprotective activity in a concentration of 10 μM, and the peptide increased the viability of cells of the Neuro2a murine neuroblastoma by 39.4 ± 6.6% in the presence of β-amyloid. However, the peptide did not influence the viability of the cells during their incubation with 6-hydroxydofamine. |
IMIS is ontwikkeld en wordt gehost door het VLIZ.
